Search results
Stuart Schreiber is an American chemist who is the Morris Loeb Research Professor at Harvard University, a co-Founder of the Broad Institute, Howard Hughes Medical Institute Investigator, Emeritus, and a member of the National Academy of Sciences and National Academy of Medicine.
Stuart Schreiber is a Morris Loeb Professor of Chemistry and Chemical Biology, Emeritus, and a Howard Hughes Medical Institute Investigator. His lab studies the science of therapeutics, including drug discovery, cell signaling, gene regulation, and brain health.
Stuart Schreiber is a pioneer of chemical biology and a co-founder of the Broad Institute. He discovered molecular glues, PROTACs, and other small molecules that modulate biological processes and disease.
Mar 1, 2024 · Stuart Schreiber, a chemist and co-founder of The Broad Institute, discusses his plans to tackle inefficiencies in the translation of biomedical research, through the newly launched for-profit institute Arena BioWorks. He explains how Arena aims to speed up the discovery and development of new medicines for diseases such as brain health, oncology and ageing.
- Asher Mullard
The Schreiber lab led by Stuart Schreiber uses chemical biology and human biology to discover small-molecule probes and therapeutics for various diseases. Learn about their areas of focus, such as next-generation synthesis, cancer and microbial therapeutics, and novel mechanisms of action.
Jun 28, 2024 · Stuart Lee Schreiber is a chemist, chemical geneticist, and educator who founded the Broad Institute and the Center for the Science of Therapeutics. He is known for his discoveries in chemical biology, small-molecule drug discovery, and biotech entrepreneurship.
Stuart Schreiber. Morris Loeb Professor of Chemistry and Chemical Biology. Summary. Description. By examining a series of alleles linked to a disease, we can learn the effect of modulating candidate therapeutic targets in terms of both efficacy and safety.
